Research map: Real‐world risk factors and clinical implications of early estimated glomerular filtration rate decline after sodium‐glucose cotransporter‐2 inhibitor therapy

Back to the article

Papers in this map

  1. A New Equation to Estimate Glomerular Filtration Rate · Andrew S. Levey · 2009 · 26117 citations · Cited by this paper
  2. Elevated serum galectin‐3 levels predict the incidence of type 2 diabetes mellitus in a Japanese general population: A 10‐year follow‐up study · 2026 · Related
  3. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease · Paul E. Stevens · 2024 · 8239 citations · Cited by this paper
  4. Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trial · 2026 · Related
  5. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes · Stephen D. Wiviott · 2018 · 6475 citations · Cited by this paper
  6. Machine learning‐based prediction model for adverse pregnancy outcomes in women with gestational diabetes mellitus · 2026 · Related
  7. Dapagliflozin in Patients with Chronic Kidney Disease · Hiddo J.L. Heerspink · 2020 · 5532 citations · Cited by this paper
  8. Effectiveness of tirzepatide in Japanese patients with type 2 diabetes but no obesity: A sub‐analysis of Hokkaido‐ TZP study data · 2026 · Related
  9. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes · Christoph Wanner · 2016 · 3687 citations · Cited by this paper
  10. Response to: Methodological concerns on the predictive performance evaluation of anthropometric indices · 2026 · Related
  11. Empagliflozin in Patients with Chronic Kidney Disease · The EMPA-KIDNEY Collaborative Group · 2022 · 2647 citations · Cited by this paper
  12. Sudomotor dysfunction in people with type 1 diabetes with and without clinical peripheral neuropathy: A study from Pune, India · 2026 · Related
  13. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association · Janani Rangaswami · 2019 · 1421 citations · Cited by this paper
  14. Improved prognosis prediction of all‐cause mortality and cardiovascular events by combined assessment of both ankle‐brachial index and brachial‐ankle pulse wave velocity in individuals with diabetes: The Kyushu prevention study for atherosclerosis, a prospective, multicenter survey · 2026 · Related
  15. A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases · Kitty J. Jager · 2019 · 625 citations · Cited by this paper
  16. The miR ‐145‐5p/ NRF2 / SLC7A11 axis regulates ferroptosis‐mediated renal tubular epithelial cell injury in diabetic nephropathy · 2026 · Related
  17. Trajectories of kidney function in diabetes: a clinicopathological update · Megumi Oshima · 2021 · 353 citations · Cited by this paper
  18. USP30 inhibits wound healing in diabetic foot ulcers by promoting TRAF6 ‐induced ferroptosis and angiogenesis inhibition · 2026 · Related
  19. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study · Hiddo J.L. Heerspink · 2019 · 316 citations · Cited by this paper
  20. The positive correlation between the progressive photoreceptor damage and the increased macular leakage indicating the severity of diabetic retinopathy · 2026 · Related
  21. Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease · Clifford J. Bailey · 2022 · 250 citations · Cited by this paper
  22. Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations · Kevin Yau · 2022 · 223 citations · Cited by this paper
  23. Characterization and implications of the initial estimated glomerular filtration rate ‘dip’ upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial · Bettina Johanna Kraus · 2020 · 218 citations · Cited by this paper
  24. Atrial Fibrillation · Darae Ko · 2024 · 188 citations · Cited by this paper
  25. Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice · Megumi Oshima · 2020 · 166 citations · Cited by this paper
  26. Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis · Eneyew Talie Fenta · 2023 · 134 citations · Cited by this paper
  27. Cardiovascular Disease in Diabetes and Chronic Kidney Disease · Sowmya Swamy · 2023 · 75 citations · Cited by this paper
  28. Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition · Yuliya Lytvyn · 2022 · 71 citations · Cited by this paper
  29. Clinical Implications of Estimated Glomerular Filtration Rate Dip Following Sodium‐Glucose Cotransporter‐2 Inhibitor Initiation on Cardiovascular and Kidney Outcomes · Yan Xie · 2021 · 47 citations · Cited by this paper
  30. Visit-to-visit variability in estimated glomerular filtration rate predicts hospitalization and death due to cardiovascular events · Akira Suzuki · 2019 · 26 citations · Cited by this paper
  31. Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial · David Z.I. Cherney · 2022 · 24 citations · Cited by this paper
  32. Healthcare Costs Across Diabetic Kidney Disease Stages: A Veterans Affairs Study · Kibum Kim · 2024 · 23 citations · Cited by this paper
  33. The Contribution of Kidney Disease to Cognitive Impairment in Patients with Type 2 Diabetes · Shivani Ghoshal · 2020 · 20 citations · Cited by this paper
  34. Rapid decline in kidney function is associated with rapid deterioration of health-related quality of life in chronic kidney disease · Hyo Jin Kim · 2023 · 17 citations · Cited by this paper
  35. Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial · Min Jun · 2021 · 15 citations · Cited by this paper
  36. Risk factors for rapid kidney function decline in diabetes patients · Jixin Xing · 2024 · 12 citations · Cited by this paper
  37. GFR Variability, Survival, and Cardiovascular Events in Older Adults · Michelle A. Fravel · 2022 · 11 citations · Cited by this paper
  38. Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis · Min‐Hsiang Chuang · 2024 · 11 citations · Cited by this paper
  39. Hip Fracture Risk According to Diabetic Kidney Disease Phenotype in a Korean Population · Seung Eun Lee · 2022 · 10 citations · Cited by this paper

Source: OpenAlex (CC0)